RU99103901A - METHOD FOR MEDICINAL TREATMENT OF MALIGNANT TUMORS - Google Patents

METHOD FOR MEDICINAL TREATMENT OF MALIGNANT TUMORS

Info

Publication number
RU99103901A
RU99103901A RU99103901/14A RU99103901A RU99103901A RU 99103901 A RU99103901 A RU 99103901A RU 99103901/14 A RU99103901/14 A RU 99103901/14A RU 99103901 A RU99103901 A RU 99103901A RU 99103901 A RU99103901 A RU 99103901A
Authority
RU
Russia
Prior art keywords
malignant tumors
medicinal treatment
treatment
medicinal
oxygen
Prior art date
Application number
RU99103901/14A
Other languages
Russian (ru)
Inventor
Э.Б. Дорфман
Original Assignee
Э.Б. Дорфман
Filing date
Publication date
Application filed by Э.Б. Дорфман filed Critical Э.Б. Дорфман
Publication of RU99103901A publication Critical patent/RU99103901A/en

Links

Claims (1)

Способ медикаментозного лечения злокачественных опухолей, отличающийся тем, что для опухолевой ткани устанавливают режим кислородного голодания путем ввода в нее раствора вещества, способного активно связывать кислород.The method of drug treatment of malignant tumors, characterized in that for the tumor tissue establish the regime of oxygen starvation by introducing into it a solution of a substance that can actively bind oxygen.
RU99103901/14A 1999-02-22 METHOD FOR MEDICINAL TREATMENT OF MALIGNANT TUMORS RU99103901A (en)

Publications (1)

Publication Number Publication Date
RU99103901A true RU99103901A (en) 2000-12-10

Family

ID=

Similar Documents

Publication Publication Date Title
CY1107838T1 (en) ADAMANTANIUM PRODUCTION FOR THE TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND CARDIOGRAPHIC DISEASES
WO2000061612A3 (en) Compounds and methods for therapy and diagnosis of lung cancer
PL354540A1 (en) Drugs for the treatment of malignant tumours
IL138330A0 (en) Polynucleotides, polypeptides and pharmaceutical compositions for treating lung cancer
WO2002087555A3 (en) Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
EP1285092A4 (en) Methods for drug discovery, disease treatment, and diagnosis using metabolomics
HUP0203238A3 (en) Drugs for the treatment of malignant tumours, process for their preparation and pharmaceutical compositions containing them
IT1307266B1 (en) APPARATUS FOR INFUSION OF DRUGS.
DK1308168T3 (en) New anti-cancer drugs
CY1112184T1 (en) PYRIDOXAMINE FOR USE IN TREATMENT OF DIABETIC Nephropathy in Type II Diabetes
EP1964850A3 (en) Compositions and methods for the treatment and diagnosis of breast cancer
BR9813318A (en) Process of treating tumors and macular degeneration in a human or veterinary patient, pharmaceutical composition for treating tumors and macular degeneration in a human or veterinary patient
WO2000061756A3 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
EP2286826A3 (en) Treatment of tumor metastase and cancer
AU6583700A (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
EP1208840A3 (en) Combination of fluorouracil and a methylol transfer agent for the treatment of tumor metastases and cancer
IL142581A (en) Medicament for treating heart disease
RU99103901A (en) METHOD FOR MEDICINAL TREATMENT OF MALIGNANT TUMORS
MXPA01010186A (en) Compositions and methods for the treatment and diagnosis of breast cancer.
DE602005026510D1 (en) Anthracyclinderivate
IS8356A (en) Medications, methods and dose control for the treatment and prevention of acute coronary heart disease
RU99107828A (en) METHOD FOR TREATMENT OF PATHOLOGICAL ADDICTION TO DRUGS IN OPIEN DRUG PATIENTS
RU2001112731A (en) A method of treating cancer patients
ZA200300675B (en) Pharmaceutical preparation of the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma.